Online Programme 2020

Programme

To download the programme as a PDF please click here

09:00 - 10:00

Registration, networking and refreshments

09:45 - 10:00

Chair’s opening remarks

Ben Clover, Bureau Chief, HSJ

10:00 - 10:30

Keynote presentation:
National update: How we are progressing on commitments one year on from the long term plan

  • Find out how we have progressed since January 2019 and what the next steps are
  • Understand the structural and system changes, such as Primary Care Networks, and their potential for impact on patient outcomes
  • Gain clarity on the role of the Cancer Alliances in driving local momentum for change

10:30 - 11:05

Panel discussion:
Preventing cancer: the role of public health messaging

  • Consider the importance of national public health campaigns vs local campaigns
  • Understand the roles of primary and acute care in prevention
  • Learn about the impact of campaigns, including on the demand for screening and the gap between more affluent and more deprived communities

Panellists include:

Freya Howle, CURE Programme Lead, Greater Manchester Cancer

Sheila Mitchell, Director of Marketing, Public Health England (invited)

Dr Pawan Randev, GP Cancer Lead, East Midlands Cancer Alliance and East Midlands Cancer Network (invited)

Barbara Rice, Team Leader and Operational Manager, Healthwatch Thurrock

11:05 – 11:20

Morning refreshments and networking

11:20 – 12:05

Interactive Discussion Groups

Join these focused small group discussions to share experiences with colleagues, learn from each other and get your pressing questions answered. With the number of participants per table limited, make sure you sign up early to ensure your place at your two preferred tables

Pooling resources via regional networking Improving performance against cancer standards
Commissioning novel cancer drugs Funding innovative work
Supporting people living with and beyond cancer Ensuring patient centred outcomes
Dealing with the complexity of clinical trials Managing the workforce shortage

12:05 – 13:05

Lunch and networking

Breakout sessions

The following sessions give you the opportunity to go into more detail on key topics with presentations and discussions from experts and trailblazers. ‘Solution’ sessions take a closer look at current challenges and the practical strategies for addressing them. ‘Opportunity’ sessions take a forward-look at some of the most exciting innovations and ground-breaking work.

 

Solutions stream

Opportunities stream

13:05 – 13:45

Solutions:
Practical strategies for doing the best with the capacity and workforce we have

  • Find out about some of the innovative ways others are tackling staff shortages
  • Discover the potential for AI in supporting the workforce and how to upskill for future demand
  • Learn about the practical considerations of regional collaboration, including governance

John Renninson, Clinical Lead, Peninsula Cancer Alliance

Opportunities:
Realistically, is data a means to equity of care?

  • Understand what the data shows us regarding variances in access to treatment and response to treatment
  • Learn about the limitations of current available data, as shown by work with The Christie FT
  • Discuss the opportunities and further work needed to progress and identify effectiveness of treatments and improve outcomes

Andi Orlowski, Deputy Director of Business Intelligence, Imperial College Health Partners

James Peach, Interim COO/CCO, DATA CAN

James Warburton, Medical Director, Oncology, Novartis

13:45 – 13:50

Session change

13:50 – 14:30

Solutions:
How to improve pathways to ensure they are best for the patient

  • Discuss how we ensure the most appropriate pathways are in place for patients
  • Learn how GIRFT methodology can be used to improve pathways and promotes QI solutions
  • Reflecting the impact of changing pathways on the workforce, to ensure that patient needs are met

Debra Palmer, Senior Transformation Manager, West Midlands Cancer Alliance

Dr Liz Toy, Clinical Lead Lung Cancer, GIRFT

Opportunities:
What the future holds for cancer treatments

  • Learn about innovative, new and future cancer treatments from those creating and commissioning them
  • Understand what you need to do now, in order to ensure you are ready for future treatments
  • Discuss how to reduce variations in access to the most effective treatments

14:30 – 14:35

Session change

14:35 – 15:15

Solutions:
Understanding the impact of multidisciplinary team meetings reform

  • Understand how to improve the effectiveness of MDTMs
  • Discuss the impact any changes will have on efficiency and effectiveness of both the meetings and the wider workforce
  • Learn how to achieve the full benefits of streamlining MDTMs

Chris Harrison, Medical Director, The Christie FT

Opportunities:
Rapid Diagnostic Centres: The rural approach

  • Hear two different approaches to rapid diagnosis in rural areas
  • Understand how the approaches meet the specific needs of the areas
  • Consider how to establish the best model of RDC for your area

Joe Mays, Lead for Prevention and Early Diagnosis, Peninsula Cancer Alliance

Amelia Randle, Clinical Director, SWAG Cancer Alliance

15:15 – 15:45

Afternoon refreshments and networking

15:45 – 16:15

Keynote presentation:
What does it mean to be a ‘cancer patient’? Stepping outside the health system

  • How to help people feel autonomous, exploring the questions we really want to ask… but are sometimes worried to!
  • Think about the difference between clinical outcomes and patient outcomes
  • Learn what practical steps you can take to refocus on the issues that really matter to those facing cancer

Laura Fulcher, Founder, Mission Remission

16:15 – 16:30

Presentation:
Horizon scanning: Disrupting research cycles for real world outcomes

  • Understand how research and real world outcomes are fundamentally connected in work at the University of Manchester
  • Learn what this research means for understanding clinical complexity and pathways
  • How clinical groups, commissioners and researchers can work together to improve outcomes for complex cases, including comorbidity

Professor Rob Bristow, Director of Manchester Cancer Research Centre, The University of Manchester

16:30-17:00

Panel discussion:
Horizon-scanning: What the next 12 months will hold

  • Examine the range of opportunities and solutions for the coming year, including new technology, novel treatments and national work
  • Discuss how to get to where we need to be in order to achieve national and local aims
  • Learn about the support and solutions available to enable your plans to progress

Professor Rob Bristow, Director of Manchester Cancer Research Centre, The University of Manchester

Steve Williamson, Lead Cancer Pharmacist, NHS England and Improvement

17:00 – 18:00

Chair’s closing remarks followed by networking reception

Ben Clover, Bureau Chief, HSJ

By continuing to use the site you agree to our cookies policy. Accept